Neogenomics NEO
NASDAQ NEO
$19.14 -0.27 (-1.42%)
As of: Sep 22, 2026 · 10:53 AM EDT

Neogenomics (NEO) Cash & Current Investments (2010 - 2026)

Neogenomics' (NEO) quarterly Cash & Current Investments came in at $145.5 million in Q2 2026, down 11.09% on a YoY basis from $163.7 million in Q2 2025, and little changed quarter-over-quarter from $146.1 million in Q1 2026.

Analysis

Neogenomics (NEO) Cash & Current Investments (2010 - 2026) Analysis & Trends

Neogenomics (NEO) has reported Cash & Current Investments for 17 consecutive years, with $145.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash & Current Investments fell 11.09% year-over-year to $145.5 million; the trailing twelve-month figure through Jun 2026 stood at $145.5 million (down 11.09% YoY), and the FY2025 full-year result was $159.6 million, down 58.74% from the prior year.
  • Cash & Current Investments steadied at $145.5 million in Q2 2026 per NEO's latest filing, from $146.1 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $481.4 million in Q1 2022 and bottomed at $145.5 million in Q2 2026.
  • Historically, Cash & Current Investments has averaged $342.1 million across 5 years, with a median of $387.8 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Cash & Current Investments fell 3.59% in 2024, then sank 59.19% in 2026.
  • Over 5 years, Cash & Current Investments stood at $438.0 million in 2022, then retreated by 5.2% to $415.2 million in 2023, then fell by 6.83% to $386.8 million in 2024, then plunged by 58.74% to $159.6 million in 2025, then declined by 8.82% to $145.5 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $145.5 million, $146.1 million, and $159.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 1.10 Bn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 626.00 Mn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 141.80 Mn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 1.05 Bn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 815.99 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 793.12 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 356.73 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 548.63 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 344.26 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn 145.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145.54 Mn
Mar 31, 2026 146.14 Mn
Dec 31, 2025 159.62 Mn
Sep 30, 2025 164.12 Mn
Jun 30, 2025 163.69 Mn
Mar 31, 2025 358.08 Mn
Dec 31, 2024 386.84 Mn
Sep 30, 2024 387.81 Mn
Jun 30, 2024 387.86 Mn
Mar 31, 2024 384.83 Mn
Dec 31, 2023 415.20 Mn
Sep 30, 2023 402.26 Mn
Jun 30, 2023 409.35 Mn
Mar 31, 2023 417.92 Mn
Dec 31, 2022 437.99 Mn
Sep 30, 2022 443.54 Mn
Jun 30, 2022 465.95 Mn
Mar 31, 2022 481.43 Mn
Dec 31, 2021 515.39 Mn
Sep 30, 2021 542.71 Mn
API Access

Neogenomics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NEO&period=max&api_key=YOUR_API_KEY